AVDL
Avadel Pharmaceuticals
AVDL
AVDL
175 hedge funds and large institutions have $976M invested in Avadel Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 58 increasing their positions, 43 reducing their positions, and 25 closing their positions.
Holders
175
Holders Change
+21
Holders Change %
+13.64%
% of All Funds
2.53%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
46
Increased
58
Reduced
43
Closed
25
Calls
$35.8M
Puts
$48.9M
Net Calls
-$13M
Net Calls Change
-$33.5M
Top Buyers
1 |
1
Goldman Sachs
New York
|
$24.4M |
2 |
2
Millennium Management
New York
|
$12.8M |
3 |
PCM
3
Penn Capital Management
Philadelphia,
Pennsylvania
|
$8M |
4 |
4
Northern Trust
Chicago,
Illinois
|
$7.76M |
5 |
B
5
Braidwell
Stamford,
Connecticut
|
$44.4M |